Your browser doesn't support javascript.
loading
Muscle MRI in a large cohort of patients with oculopharyngeal muscular dystrophy.
Alonso-Jimenez, Alicia; Kroon, Rosemarie H M J M; Alejaldre-Monforte, Aida; Nuñez-Peralta, Claudia; Horlings, Corinne G C; van Engelen, Baziel G M; Olivé, Montse; González, Laura; Verges-Gil, Enric; Paradas, Carmen; Márquez, Celedonio; Garibaldi, Matteo; Gallano, Pía; Rodriguez, Maria José; Gonzalez-Quereda, Lidia; Dominguez Gonzalez, Cristina; Vissing, John; Fornander, Freja; Eisum, Anne-Sofie Vibæk; García-Sobrino, Tania; Pardo, Julio; García-Figueiras, Roberto; Muelas, Nuria; Vilchez, Juan Jesús; Kapetanovic, Solange; Tasca, Giorgio; Monforte, Mauro; Ricci, Enzo; Gomez, María Teresa; Bevilacqua, Jorge Alfredo; Diaz-Jara, Jorge; Zamorano, Ivonne Ingrid; Carlier, Robert Yves; Laforet, Pascal; Pelayo-Negro, Ana; Ramos-Fransi, Alba; Martínez, Amaia; Marini-Bettolo, Chiara; Straub, Volker; Gutiérrez, Gerardo; Stojkovic, Tanya; Martín, María Asunción; Morís, Germán; Fernández-Torrón, Roberto; Lopez De Munaín, Adolfo; Cortes-Vicente, Elena; Querol, Luis; Rojas-García, Ricardo; Illa, Isabel; Diaz-Manera, Jordi.
Afiliación
  • Alonso-Jimenez A; Neuromuscular Disorders Unit, Neurology Department, Hospital de la Santa Creu I Sant Pau, Universidad Autónoma de Barcelona, Barcelona, Spain.
  • Kroon RHMJM; Rehabilitation Department, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Alejaldre-Monforte A; Neurology Department, Hospital de Sant Joan Despí Moisès Broggi, Barcelona, Spain.
  • Nuñez-Peralta C; Radiology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Horlings CGC; Neurology Department, Radboud university Medical Center, Nijmegen, The Netherlands.
  • van Engelen BGM; Neurology Department, Radboud university Medical Center, Nijmegen, The Netherlands.
  • Olivé M; Pathology Department (Neuropathology), Neuromuscular Disorders Unit, IDIBELL, Hospital de Bellvitge, Barcelona, Spain.
  • González L; Pathology Department (Neuropathology), Neuromuscular Disorders Unit, IDIBELL, Hospital de Bellvitge, Barcelona, Spain.
  • Verges-Gil E; Pathology Department (Neuropathology), Neuromuscular Disorders Unit, IDIBELL, Hospital de Bellvitge, Barcelona, Spain.
  • Paradas C; Neuromuscular Disorders Unit, Neurology Department, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla, Sevilla, Spain.
  • Márquez C; Neuromuscular Disorders Unit, Neurology Department, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla, Sevilla, Spain.
  • Garibaldi M; Neuromuscular Disorders Unit, Department of Neurology, Mental Health and Sensory Organs (NESMOS), SAPIENZA University of Rome, Ospedale Sant'Andrea, Rome, Italy.
  • Gallano P; Genetic Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Rodriguez MJ; Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Valencia, Spain.
  • Gonzalez-Quereda L; Genetic Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Dominguez Gonzalez C; Genetic Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Vissing J; Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Valencia, Spain.
  • Fornander F; Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Valencia, Spain.
  • Eisum AV; Neuromuscular Disorders Unit, Neurology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • García-Sobrino T; Copenhagen Neuromuscular Center, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Pardo J; Copenhagen Neuromuscular Center, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • García-Figueiras R; Copenhagen Neuromuscular Center, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Muelas N; Neurology Department, Hospital Clínico, Santiago de Compostela, Spain.
  • Vilchez JJ; Neurology Department, Hospital Clínico, Santiago de Compostela, Spain.
  • Kapetanovic S; Radiology Department, Hospital Clínico, Santiago de Compostela, Spain.
  • Tasca G; Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Valencia, Spain.
  • Monforte M; Neuromuscular Research Unit, Neurology Department, Instituto de Investigación Sanitaria la Fe, Hospital Universitari i Politécnic La Fe, Valencia, Spain.
  • Ricci E; Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Valencia, Spain.
  • Gomez MT; Neuromuscular Research Unit, Neurology Department, Instituto de Investigación Sanitaria la Fe, Hospital Universitari i Politécnic La Fe, Valencia, Spain.
  • Bevilacqua JA; Neurology Department, Hospital de Basurto, Bilbao, Spain.
  • Diaz-Jara J; Unità Operativa Complessa di Neurologia, Fondazione Policlinico Universitario A, Gemelli IRCCS, Roem, Italy.
  • Zamorano II; Unità Operativa Complessa di Neurologia, Fondazione Policlinico Universitario A, Gemelli IRCCS, Roem, Italy.
  • Carlier RY; Istituto di Neurologia, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Laforet P; Unità Operativa Complessa di Neurologia, Fondazione Policlinico Universitario A, Gemelli IRCCS, Roem, Italy.
  • Pelayo-Negro A; Istituto di Neurologia, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Ramos-Fransi A; Neurology Department, Hospital Universitario Reina Sofía, Córdoba, Spain.
  • Martínez A; Departamento de Neurología y Neurocirugía, Hospital Clínico Universidad de Chile, Programa de Anatomía y Medicina Legal, Facultad de Medicina, Universidad de Chile, Santiago, Chile.
  • Marini-Bettolo C; Centro de imagenología, Hospital Clínico Universidad de Chile, Universidad de Chile, Santiago, Chile.
  • Straub V; Servicio de Neurología, Hospital de Puerto Montt, Servicio de Salud del Reloncavi, Los Lagos Region, Chile.
  • Gutiérrez G; Assistance Publique des Hôpitaux de Paris (AP-HP), Service d'Imagerie Médicale, Pôle Neuro-locomoteur, Hôpital Raymond Poincaré, Garches, Hôpitaux Universitaires Paris-Ile-de-France Ouest, Garches, France.
  • Stojkovic T; Assistance Publique des Hôpitaux de Paris (AP-HP), Service de neurologie, Pôle Neuro-locomoteur, Hôpital Raymond Poincaré, Garches, Hôpitaux Universitaires Paris-Ile-de-France Ouest, Garches, France.
  • Martín MA; Neurology Department, University Hospital "Marqués de Valdecilla (IDIVAL)", University of Cantabria, and "Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED)", Santander, Spain.
  • Morís G; Neurology Department, Hospital Germans Trias I Pujol, Barcelona, Spain.
  • Fernández-Torrón R; Neurology Department, Hospital Galdakao, Vizkaia, Spain.
  • Lopez De Munaín A; The John Walton Muscular Dystrophy Research Centre, MRC Centre for Neuromuscular Diseases Institute of Genetic Medicine, University of Newcastle, Newcastle upon Tyne, UK.
  • Cortes-Vicente E; The John Walton Muscular Dystrophy Research Centre, MRC Centre for Neuromuscular Diseases Institute of Genetic Medicine, University of Newcastle, Newcastle upon Tyne, UK.
  • Querol L; Neurology Department, Hospital Infanta Sofía, San Sebastián de los Reyes, Spain.
  • Rojas-García R; Institute of Myology, Pitié-Salpêtrière Hospital, Paris, France.
  • Illa I; Neurology Department, Complejo asistencial hospitalario de Burgos, Burgos, Spain.
  • Diaz-Manera J; Neurology Department, Hospital Universitario Central de Asturias, Asturias, Spain.
J Neurol Neurosurg Psychiatry ; 90(5): 576-585, 2019 05.
Article en En | MEDLINE | ID: mdl-30530568
ABSTRACT
BACKGROUND AND

OBJECTIVE:

Oculopharyngeal muscular dystrophy (OPMD) is a genetic disorder caused by an abnormal expansion of GCN triplets within the PABPN1 gene. Previous descriptions have focused on lower limb muscles in small cohorts of patients with OPMD, but larger imaging studies have not been performed. Previous imaging studies have been too small to be able to correlate imaging findings to genetic and clinical data.

METHODS:

We present cross-sectional, T1-weighted muscle MRI and CT-scan data from 168 patients with genetically confirmed OPMD. We have analysed the pattern of muscle involvement in the disease using hierarchical analysis and presented it as heatmaps. Results of the scans were correlated with genetic and clinical data.

RESULTS:

Fatty replacement was identified in 96.7% of all symptomatic patients. The tongue, the adductor magnus and the soleus were the most commonly affected muscles. Muscle pathology on MRI correlated positively with disease duration and functional impairment.

CONCLUSIONS:

We have described a pattern that can be considered characteristic of OPMD. An early combination of fat replacement in the tongue, adductor magnus and soleus can be helpful for differential diagnosis. The findings suggest the natural history of the disease from a radiological point of view. The information generated by this study is of high diagnostic value and important for clinical trial development.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Músculo Esquelético / Distrofia Muscular Oculofaríngea Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Neurol Neurosurg Psychiatry Año: 2019 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Músculo Esquelético / Distrofia Muscular Oculofaríngea Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Neurol Neurosurg Psychiatry Año: 2019 Tipo del documento: Article